1. Bauminger, E.R., Barcikowska, M., Friedman, A., Gałązka-Friedman, J., Hechel, D., Nowik, I.: Does iron play a role in Parkinson’s disease? Hyperfine Interact. 91, 853–856 (1994)
2. Gałązka-Friedman, J., Bauminger, E.R., Friedman, A., Barcikowska, M., Hechel, D., Nowik, I.: Iron in parkinsonian and control substantia nigra—A Mössbauer spectroscopy study. Mov. Disord. 11, 8–16 (1996)
3. Gałązka-Friedman, J., Friedman, A.: Controversies about iron in parkinsonian and control substantia nigra. Acta Neurobiol. Exp. 57, 210–225 (1997)
4. Gałązka-Friedman, J., Bauminger, E.R., Tymosz, T., Friedman, A.: Mössbauer spectroscopy, electron microscopy and electron diffraction studies of ferritin-like iron in human heart, liver and brain. Hyperfine Interact. 3, 49–52 (1998)
5. Friedman, A., Gałązka-Friedman, J.: The current state of free radicals in Parkinson’s disease. Nigral iron as a trigger of oxidative stress. Adv. Neurol. 86, 137–142 (2001)